Life Science

Over the years, Singh has taken on several leadership roles in commercial organisations such as Sigma-Aldrich and Merck India

The Mumbai-based company, which detergent maker Nirma is in the process of taking over, said its profit rose to 1.19 billion rupees ($14.32 million) in the quarter ended Dec. 31

Capgemini's survey included business leaders from 2,000 organisations in 15 countries across sectors such as automotive, consumer products, banking, capital markets, life sciences, etc

Generic API revenues increased by 19.7 percent this quarter due to growth in US, LATAM and Europe regulated markets

Punit Patel will oversee the business operations of all Zydus entities in North America, including generics, injectables, specialty business, rare and orphan disease portfolio

The newly unveiled manufacturing facility in Pune will produce bioprocessing equipment, including tangential flow, virus filtration, and inactivation systems

Aiming to position Hyderabad as the "Health-Tech Mecca" of the world, Telangana Minister for IT and Industries K T Rama Rao on Friday said the government targets to triple the life sciences sector ecosystem in the state to USD 250 billion by 2030 from the existing USD 80 billion. Speaking at the 20th Edition of BioAsia 2023, a three-day life sciences conclave which began here today, KTR said the state is home to over 1,000 life sciences companies globally, including the top 10 pharma firms, in their innovation journey. He said the ecosystem value has already touched USD 80 billion in 2022 which represents a phenomenal ecosystem value growth in Telangana at a mind-boggling 23 per cent over the last two years compared to the national average of about 14 per cent. "We have a unique opportunity to help reshape the future of the life sciences industry. We need to dream big. I envision that by 2030, the value of the life sciences ecosystem will cross USD 250 billion," he said. He further

A group of neurons, called EP3 neurons, in the preoptic area of the brain play a key role in regulating body temperature in mammals, reported a research group at Nagoya University in Japan.

India's first national repository for life science data, generated from publicly-funded research in the country, was unveiled here on Thursday by Science and Technology Minister Jitendra Singh. The 'Indian Biological Data Centre' (IBDC), established at the Regional Centre of Biotechnology here, has data storage capacity of four petabytes and is also home to the 'Brahm' High Performance Computing facility. A data disaster recovery site has been set up at the National Informatics Centre, Bhubaneshwar, Singh said. Prof Sudhanshu Vrati, Executive Director of IBDC, said the life sciences data was till now stored in data repositories in Europe and the US, and a need was felt to house the data within the country. The computational infrastructure at IBDC has also been made available for researchers interested in performing computational-intensive analysis. Singh said that IBDC has started nucleotide data submission services via two data portals viz. the 'Indian Nucleotide Data Archive (IN

Infosys on Wednesday said it will acquire Denmark-based BASE life science for about 110 million euros (Rs 875 crore) in an all-cash deal. The acquisition will deepen Infosys' expertise in life sciences domain as well as strengthen its footprint across Europe. "This acquisition augments Infosys' deep life sciences expertise, and expands our footprint further in the Nordics region and across Europe, and scales our digital transformation capabilities with cloud-based industry solutions. "We are excited to welcome BASE life science and its leadership team into the Infosys family," Infosys president Ravi Kumar S said. The deal is expected to close during the second quarter of current fiscal. BASE brings to Infosys, domain experts with commercial, medical, digital marketing, clinical, regulatory, and quality knowhow. "Backed by a team of data science specialists, BASE is at the frontier of the latest technological developments and trends. It has a strong focus on Data & AI, and the ...

Last week, scientists completed sequencing the human genome, the goal of a project that began in October 1990

According to leading global professional services firm Aon's 26th Salary Increase Survey in India, organizations across industries project a 9.9% salary increase in 2022, compared to 9.3% in 2021

The Rs 1,023.84-crore IPO received bids for 38,807,802 shares against 10,844,104 shares on offer, according to NSE

Leading life sciences company Tarsons Products on Wednesday said it has fixed a price band of Rs 635-662 a share for its Rs 1,024-crore initial share-sale. The three-day initial public offering (IPO) will open on November 15 and conclude on November 17. The bidding for anchor investors will open on November 12, the company announced. The initial share-sale comprises fresh issuance of equity shares worth Rs 150 crore and an offer for sale (OFS) of 1.32 crore equity shares by promoters and an investor. As a part of the OFS, promoters -- Sanjive Sehgal will offload up to 3.9 lakh equity shares and Rohan Sehgal will sell up to 3.1 lakh equity shares -- and investor Clear Vision Investment Holdings Pte Ltd will divest up to 1.25 crore equity shares. At the upper end of the price band, the IPO is expected to fetch Rs 1,024 crore. The public issue will include a reservation of 60,000 equity shares for employees. ICICI Securities, Edelweiss Financial Services and SBI Capital Markets are

The initial share sale of life sciences company Tarsons will open for public subscription on November 15.

HCL Technologies on Monday said it has expanded its strategic partnership with Google Cloud to jointly launch healthcare and life sciences solutions for customers

DCGI on Friday granted permission to the Mukesh Ambani-owned Reliance Life Sciences to conduct phase-I clinical trial of its indigenous COVID-19 vaccine with certain conditions, sources said.

The division will strengthen Bayer's presence in India

Anupam Rasayan on Wednesday said it has bagged orders worth Rs 540 crore from two multinational companies for supplying speciality chemicals

The firm raised $20 million (about Rs 145 crore) earlier this month from India Life Sciences Fund III, LLC and others